Literature DB >> 6854629

Core and E antigen synthesis in rodent cells transformed with hepatitis B virus DNA is associated with greater than genome length viral messenger RNAs.

N M Gough.   

Abstract

The viral RNA sequences in a number of rodent cell lines which contain integrated hepatitis B virus DNA were examined. In one of the cell lines, which produces the hepatitis B virus surface, core and e antigens, there are four polyadenylated, cytoplasmic RNA species, estimated to be 4425, 3968, 2435 and 1054 nucleotides in length, which hybridize with hepatitis B virus DNA. All four were shown to be transcripts of the coding strand of the virus genome and the regions contained in each RNA molecule were determined by hybridization with probes from different parts of the genome. The two largest RNAs hybridized with probes from all parts of the genome. The 2.4 x 10(3) nucleotide RNA, which is the same size as the previously identified surface antigen messenger RNA, hybridized with probes covering the surface antigen gene but not with probes corresponding to the core antigen gene. It also hybridized with a probe mapping upstream of a sequence previously suggested to be its promoter. The 10(3) nucleotide RNA was mapped to the X gene region and thus provides evidence that this open translational reading frame does encode a product. This RNA is possibly 3' coterminal with the surface antigen mRNA. The two largest RNAs, which are greater than the length of the hepatitis B virus genome, are present in three independent cell lines which produce core antigen and e antigen in addition to surface antigen, but absent from two cell lines which produce only surface antigen. Therefore, it appears that these RNAs are entirely hepatitis B virus-specified, rather than being co-transcripts with cellular sequences, and also that one of them encodes the core and e antigen produced by these cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854629     DOI: 10.1016/s0022-2836(83)80274-5

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  Transcriptional trans-activating function of hepatitis B virus.

Authors:  J S Twu; R H Schloemer
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Expression of hepatitis B viral core region in mammalian cells.

Authors:  M J Roossinck; S Jameel; S H Loukin; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

3.  XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.

Authors:  N Kuzhandaivelu; Y S Cong; C Inouye; W M Yang; E Seto
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

Review 4.  Hepatitis B virus components produced by the human hepatoma cell line PLC/PRF/5: do they indicate virus propagation? Brief review.

Authors:  O Marquardt
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Two parvoviruses that cause different diseases in mink have different transcription patterns: transcription analysis of mink enteritis virus and Aleutian mink disease parvovirus in the same cell line.

Authors:  T Storgaard; M Oleksiewicz; M E Bloom; B Ching; S Alexandersen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  X-region-specific transcript in mammalian hepatitis B virus-infected liver.

Authors:  S Kaneko; R H Miller
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Cell type specific expression of pre S 1 antigen and secretion of hepatitis B virus surface antigen. Brief Report.

Authors:  O Marquardt; K H Heermann; M Seifer; W H Gerlich
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Replicative intermediate of hepatitis B virus in transfected murine fibroblasts.

Authors:  A Z Zelent; M A Sells; M Shvartsman; P M Price; G Acs
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

9.  Expression of hepatitis B antigens with a simian virus 40 vector.

Authors:  H Will; R Cattaneo; E Pfaff; C Kuhn; M Roggendorf; H Schaller
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

10.  Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.

Authors:  E G Lindenschmidt; C F Granato; C Salefsky; R Laufs; H Henning
Journal:  Klin Wochenschr       Date:  1984-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.